JunB: a paradigm for Jun family in immune response and cancer

被引:33
作者
Ren, Fu-jia [1 ]
Cai, Xiao-yu [2 ]
Yao, Yao [3 ]
Fang, Guo-ying [1 ]
机构
[1] Hangzhou Womens Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ Sch Med, Affiliated Hangzhou Peoples Hosp 1, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejiang, Dept Clin Pharm,Sch Med, Hangzhou 310006, Peoples R China
[3] Zhejiang Univ, Womens Hosp, Sch Med, Dept Pharm, Hangzhou, Peoples R China
关键词
AP-1; JunB; immune response; tumorigenesis; tumor microenvironment; TRANSCRIPTION FACTOR JUNB; EPITHELIAL-MESENCHYMAL TRANSITION; CHRONIC MYELOID-LEUKEMIA; STEM-CELL PROLIFERATION; MICE LACKING JUNB; HODGKIN LYMPHOMA; C-JUN; GENE-EXPRESSION; DOWN-REGULATION; POOR-PROGNOSIS;
D O I
10.3389/fcimb.2023.1222265
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Jun B proto-oncogene (JunB) is a crucial member of dimeric activator protein-1 (AP-1) complex, which plays a significant role in various physiological processes, such as placental formation, cardiovascular development, myelopoiesis, angiogenesis, endochondral ossification and epidermis tissue homeostasis. Additionally, it has been reported that JunB has great regulatory functions in innate and adaptive immune responses by regulating the differentiation and cytokine secretion of immune cells including T cells, dendritic cells and macrophages, while also facilitating the effector of neutrophils and natural killer cells. Furthermore, a growing body of studies have shown that JunB is involved in tumorigenesis through regulating cell proliferation, differentiation, senescence and metastasis, particularly affecting the tumor microenvironment through transcriptional promotion or suppression of oncogenes in tumor cells or immune cells. This review summarizes the physiological function of JunB, its immune regulatory function, and its contribution to tumorigenesis, especially focusing on its regulatory mechanisms within tumor-associated immune processes.
引用
收藏
页数:16
相关论文
共 116 条
[1]   Gene signatures with therapeutic value: emerging perspective for personalized immunotherapy in renal cancer [J].
Ahluwalia, Pankaj ;
Mondal, Ashis K. ;
Sahajpal, Nikhil S. ;
Rojiani, Mumtaz, V ;
Kolhe, Ravindra .
IMMUNOTHERAPY, 2021, 13 (18) :1535-1547
[2]   The E3 ligase Itch in immune regulation and beyond [J].
Aki, Daisuke ;
Zhang, Wen ;
Liu, Yun-Cai .
IMMUNOLOGICAL REVIEWS, 2015, 266 (01) :6-26
[3]   CCL2 as a potential therapeutic target for clear cell renal cell carcinoma [J].
Arakaki, Ryuichiro ;
Yamasaki, Toshinari ;
Kanno, Toru ;
Shibasaki, Noboru ;
Sakamoto, Hiromasa ;
Utsunomiya, Noriaki ;
Sumiyoshi, Takayuki ;
Shibuya, Shinsuke ;
Tsuruyama, Tatsuaki ;
Nakamura, Eijiro ;
Ogawa, Osamu ;
Kamba, Tomomi .
CANCER MEDICINE, 2016, 5 (10) :2920-2933
[4]   Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression [J].
Bakiri, L ;
Lallemand, D ;
Bossy-Wetzel, E ;
Yaniv, M .
EMBO JOURNAL, 2000, 19 (09) :2056-2068
[5]   Molecular profiling of inflammatory breast cancer:: Identification of a poor-prognosis gene expression signature [J].
Bièche, I ;
Lerebours, F ;
Tozlu, S ;
Espie, M ;
Marty, M ;
Lidereau, R .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6789-6795
[6]   JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation [J].
Carr, Tiffany M. ;
Wheaton, Joshua D. ;
Houtz, Geoffrey M. ;
Ciofani, Maria .
NATURE COMMUNICATIONS, 2017, 8
[7]   Targeting macrophages: therapeutic approaches in cancer [J].
Cassetta, Luca ;
Pollard, Jeffrey W. .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :887-904
[8]   USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein [J].
Chen, Siyuan ;
Yun, Fenglin ;
Yao, Yikun ;
Cao, Mengtao ;
Zhang, Yifan ;
Wang, Jingjing ;
Song, Xinyang ;
Qian, Youcun .
JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 215 (11) :2850-2867
[9]   JunB/AP-1 and NF-κB-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages [J].
Cho, MK ;
Suh, SH ;
Kim, SG .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2002, 6 (03) :319-332
[10]   Skp2 promotes APL progression through the stabilization of oncoprotein PML-RARα and the inhibition of JunB expression [J].
Dan, Wenran ;
Zhong, Liang ;
Yu, Lihua ;
Xiong, Ling ;
Li, Jian ;
Ye, Jiao ;
Luo, Xu ;
Liu, Chen ;
Chu, Xuan ;
Liu, Beizhong .
LIFE SCIENCES, 2022, 289